Pharmaceutical Executive-02-01-2019

Pharmaceutical Executive
Features

February 19, 2019

Dr. Lingshi Tan, a director at DIA, and chairman and CEO of Shanghai-based CRO dMed Company Limited, which he founded after establishing R&D operations for Pfizer in China, discusses the nation's regulatory evolution and opportunities for its government to strengthen collaborations with FDA and other leading global agencies.

Pharmaceutical Executive
Features

February 10, 2019

How innovation growth has upped the pressure on China to compete globally, forcing upgrades in regulatory, quality, and standards.

Pharmaceutical Executive
Features

February 09, 2019

How the nation’s rapidly changing regulatory climate is creating a new landscape for pharmaceutical service providers

Pharmaceutical Executive

Event-hopping from big biz to high tech leaves same takeaway: Adaptive leadership-not innovation-is key to future synergy.

Pharmaceutical Executive
Features

February 08, 2019

Pharm Exec profiles Dr. Xiaobin Wu, an accomplished leader in helming China operations at big pharmas such as Pfizer and Bayer, who believes his recent jump to biotech as GM of China and president of BeiGene will deliver his most lasting legacy.

Pharmaceutical Executive
From the Editor

February 08, 2019

Green-lighting China as our coverage focus in the February issue wasn't without conflict or hesitation, but as our reporting of the nation's biopharma landscape shows, perseverance and growth many times go hand-in-hand.

Pharmaceutical Executive
Columns

February 07, 2019

Drug importing, advertising, rebates, and industry practices are on the table as legislators zero in on pharma pricing strategies.

Pharmaceutical Executive
Features

February 06, 2019

Momentum and uncertainty shape the sector's economic picture.

Pharmaceutical Executive
Features

February 06, 2019

What the new rules mean for Chinese-related investments and acquisitions in the US.

Pharmaceutical Executive
Columns

February 01, 2019

The talent and tenacity of immigrants can help drive the life sciences industry into the future, if we have the will and the wisdom to encourage it.

Issue PDF
Pharmaceutical Executive

February 01, 2019

Click the title above to open the Pharmaceutical Executive February 2019 issue in an interactive PDF format.

Special Sponsored Section
Pharmaceutical Executive

February 01, 2019

With Spain now squarely on the road to economic recovery following the ravages of the global financial crisis, multinational pharmaceutical companies are seeing the country as a top-tier investment destination once more.